Abstract:Background: Metastasis-associated protein 1 (MTA1) plays an important role in various cancers by promoting epithelial-mesenchymal transition (EMT), which also contributes to the development of endometriosis. However, the association between MTA1 and endometriosis is little known and needs to be revealed. Methods: The study population consisted of 33 women with histologically proven endometriosis and 20 endometriosis-free controls. Immunohistochemistry(IHC) and Western blotting(WB) were performed to evaluate MTA1 expression in different tissues. Primary cells isolation and culture, gene transfection, Scratch wound assay and Transwell assay were used to analyse the effect of MTA1 on migration and invasion in endometrial cells. We analyzed Gene Expression Omnibus (GEO) and RNA Sequencing (RNA-seq) datesets to find a promising target—ZEB2. Immunoprecipitation (IP) was performed to show a interaction between MTA1 and ZEB2. Establishing a mouse model of endometriosis with 18 nude mice. Besides, treatment with resveratrol in both cells and mice were used to validate the findings. Findings: MTA1 expression was significantly higher in patients with endometriosis compared with controls and was related to revised American Fertility Society (r-AFS) classification. Up-regulation or down-regulation of MTA1 in ESCs resulted in an enhancement or inhibition on cells migration and invasion abilities respectively, as well as the change of E-cadherin and Vimentin expression. Via analyzing the dateset of GEO and RNA-seq after MTA1 knockdown, we found ZEB2 were high expressed in endometriosis tissues and contributed to endometrial cells migration and invasion abilities, which could be down-regulated by MTA1. Further, we found a physical combination between MTA1 and ZEB2. In addition, we found resveratrol repressed endometrial cells metastasis via decreasing MTA1 and ZEB2 expression. To valid these findings, we established a mice endometriosis model. The results coincided with the in vitro study that MTA1 and ZEB2 were overexpressed in ectopic tissues and resveratrol treatment led to an inhibition of ectopic tissue growth and decreased expression of MTA1 and ZEB2, as well as decreased Vimentin and increased E-cadherin expression. Overall, MTA1-ZEB2 acts as a regulator of EMT and enhances endometrial cells migration and invasion abilities, subsequently appears to promote the pathogenesis of endometriosis. Interpretation: This study provides new insight that MTA1 is upregulated and promotes EMT via interacting with ZEB2 in endometriosis. However, further studies are necessary to elucidate the precise mechanism of interacting between MTA1 and ZEB2.Funding Statement: This work was supported by the National Natural Science Foundation of China (81972434) and the Nanjing Medical Science and Technique Development Foundation (ZKX17015) to H. Z, as well the National Natural Science Foundation of China (81300490) and the Nanjing Medical Science and Technique Development Foundation (QRX11074) to Y.G. Declaration of Interests: The authors have declared that no conflict of interest exists.Ethics Approval Statement: The study was approved by the Ethics Committee of The Affiliated Drum Tower Hospital of Nanjing University Medical School. Written informed consents were provided by all study patients prior to sampling and all experiments in nude mice were also performed in strict accordance with protocols approved by the institutional experimental animal review board of The Affiliated Drum Tower Hospital of Nanjing University Medical School.

Huwe1 inactivation promotes ovarian cancer metastasis by extracellular matrix deregulation

Effect of Down-Regulated Transcriptional Repressor ZEB1 on the Epithelial-Mesenchymal Transition of Ovarian Cancer Cells

HMOX1: A pivotal regulator of prognosis and immune dynamics in ovarian cancer

Hematological and Neurological Expressed 1 Promotes Tumor Progression Through mTOR Signaling in Ovarian Cancer

HIF‐1α Binding to AEG‐1 Promoter Induced Upregulated AEG‐1 Expression Associated with Metastasis in Ovarian Cancer

HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer

Zinc transporter SLC39A13/ZIP13 facilitates the metastasis of human ovarian cancer cells via activating Src/FAK signaling pathway

Overexpression of hypoxia-inducible factor 1α induces migration and invasion through Notch signaling

Hypoxia promotes HO-8910PM ovarian cancer cell invasion via Snail-mediated MT1-MMP upregulation

Overexpression of zinc finger DHHC-type containing 1 is associated with poor prognosis and cancer cell growth and metastasis in uterine corpus endometrial carcinoma

HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer

MTA1 is Up-Regulation Expression in Endometriosis and Promotesepithelial-Mesenchymal Transition of Endometriosis Via ZEB2

HMGA2 promotes cancer metastasis by regulating epithelial–mesenchymal transition

Overexpression of TMEFF1 in Endometrial Carcinoma and the Mechanism Underlying its Promotion of Malignant Behavior in Cancer Cells

Exosome-mediated transfer of CD44 from high-metastatic ovarian cancer cells promotes migration and invasion of low-metastatic ovarian cancer cells

Ovarian tumorB1-mediated heat shock transcription factor 1 deubiquitination is critical for glycolysis and development of endometriosis

SOX9/NFIA promotes human ovarian cancer metastasis through the Wnt/β-catenin signaling pathway

Extracellular matrix protein ITGBL1 promotes ovarian cancer cell migration and adhesion through Wnt/PCP signaling and FAK/SRC pathway

Metastasis Suppressor 1 Expression in Human Ovarian Cancer: the Impact on Cellular Migration and Metastasis

miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma

Tumour-derived exosomal piR-25783 promotes omental metastasis of ovarian carcinoma by inducing the fibroblast to myofibroblast transition